| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $234.6M | -17.8% |
| Cost of Revenue | $209.8M | -15.2% |
| Gross Profit | $24.8M | -34.6% |
| R&D Expense | $1.6M | +15.0% |
| SG&A Expense | $16.4M | +56.0% |
| Operating Income | $1.0M | -94.7% |
| Interest Expense | $745K | -60.5% |
| Pre-tax Income | -$6.7M | -144.5% |
| Income Tax | -$655K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.4M | -35.0% |
| Accounts Receivable | $4.1M | +204.8% |
| Current Assets | $24.2M | +5.5% |
| Total Assets | $69.5M | -11.0% |
| Current Liabilities | $33.4M | +31.4% |
| Long-term Debt | $4.4M | — |
| Total Liabilities | $54.2M | -4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.6M | -28.6% |
| Investing Cash Flow | -$4.0M | +59.5% |
| Financing Cash Flow | -$11.1M | -28.7% |
| -113.8% |
| Net Income | -$6.0M | -158.7% |
| EPS (Basic) | -$0.00 | -158.6% |
| EPS (Diluted) | -$0.00 | -162.3% |
| Stockholders' Equity |
| $15.3M |
| -28.4% |